Evidence map›Paper›PMID 35500815›Full record

ArticleJournal of clinical epidemiology2022

A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation map.

Kevin Pottie, Maureen Smith, Micayla Matthews, Nancy Santesso, Olivia Magwood, Tamara Kredo, Sarah Scott, Kerin Bayliss, Ammar Saad, Rinila Haridas and 19 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Editors' Choice: August 2022.Journal of clinical epidemiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Kevin PottieSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; CT Lamont Centre for Primary Care, Bruyere Research Institute, Ottawa, Ontario, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Canada; Department of Family Medicine, Western University, London, Ontario, Canada. Electronic address: kpottie@uwo.ca.
Maureen SmithCitizen, Chair, Cochrane Consumer Network Executive, Ottawa, Ontario, Canada.
Micayla MatthewsDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Nancy SantessoDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Michael G. DeGroote Cochrane Canada and GRADE Centre, McMaster University, Hamilton, Ontario, Canada.
Olivia MagwoodCT Lamont Centre for Primary Care, Bruyere Research Institute, Ottawa, Ontario, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Canada.
Tamara KredoMichael G. DeGroote Cochrane Canada and GRADE Centre, McMaster University, Hamilton, Ontario, Canada; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.
Sarah ScottDepartment of Medicine, McMaster University, Hamilton, Ontario, Canada.
Kerin BaylissDepartment of Medicine, McMaster University, Hamilton, Ontario, Canada; National Institute for Health and Care Excellence, Manchester, UK.
Ammar SaadCT Lamont Centre for Primary Care, Bruyere Research Institute, Ottawa, Ontario, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Canada.
Rinila HaridasCT Lamont Centre for Primary Care, Bruyere Research Institute, Ottawa, Ontario, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Canada.
Nicole DetambelDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Ashley MotilallDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Yvonne TanCT Lamont Centre for Primary Care, Bruyere Research Institute, Ottawa, Ontario, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Canada.
Sally SteinbergCitizen, Lancaster High School, Hamilton, Ontario, Canada.
Justyna LitynskaEvidence Prime, Inc., Hamilton, Ontario, Canada.
Bart DietlEvidence Prime, Inc., Hamilton, Ontario, Canada.
Alfonso IoiriDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Ludovic ReveizIncident Management Systems for COVID-19 and Evidence and Intelligence for Action in Health Department, Pan American Health Organization, Washington, DC, USA.
Vivian WelchSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; CT Lamont Centre for Primary Care, Bruyere Research Institute, Ottawa, Ontario, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Canada.
Miloslav KlugarCzech National Centre for Evidence-Based Healthcare and Knowledge Translation Brno, Czech Republic.
Lawrence MbuagbawDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Maria Ximena RojasInstit d'Recerca-Servei D'Epidemiologia Clinica, Hospital de la Santa Creu i Sant Pau, Colombia.
Ivan D FlorezDepartment of Pediatrics, Universidad de Antioquia, Calle 67 No. 53-108; Medellin, Antioquia, Colombia; School of Rehabilitation Science, McMaster University, 1280 Main Street West, L8S 3L8, Hamilton, Ontario, Canada; Clinica Las Americas-AUNA, Dg.75B ##2A-80/140, Medellin, Colombia.
Tamara LotfiDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Michael G. DeGroote Cochrane Canada and GRADE Centre, McMaster University, Hamilton, Ontario, Canada.
Amir QaseemAmerican College of Physicians, Philadelphia, PA, USA.
Joseph L MathewPostgraduate Institute of Medical Education and Research, Chandigarh, India.
Elie A AklDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Peter TugwellSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; CT Lamont Centre for Primary Care, Bruyere Research Institute, Ottawa, Ontario, Canada; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Canada.
Holger J SchünemannDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Michael G. DeGroote Cochrane Canada and GRADE Centre, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesTo develop a digital communication tool to improve the implementation of up-to-date COVID-19 recommendations. Specifically, to improve patient, caregiver and public understanding of healthcare recommendations on prevention, diagnoses and treatment.

methodsMulti-stakeholder engagement design. In conjunction with the COVID-19 Recommendations and Gateway to Contextualization RecMap, we co-developed a stakeholder prioritization, drafting and editing process to enhance guideline communication and understanding.

resultsThis paper presents the multi-stakeholder development process with three distinct plain language recommendation formats: formal recommendation, good practice statement, and additional guidance. Our case study of COVID-19 plain language recommendations PLRs addresses both public health interventions (e.g., vaccination, face masks) and clinical interventions (e.g., home pulse oximetry).

conclusionThis paper presents a novel approach to engaging stakeholders in improving the communication and understanding of published guidelines during the COVID-19 pandemic.

Indexed as

COVID-19CaregiversHumansMasksPandemicsPublic HealthCOVID-19COVID-19 vaccinesGRADEGuidancePatient and public guidelinesPlain language summariesRecommendations

Identifiers

PMID35500815
PMCPMC9055415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.